
AMN Stock Forecast & Price Target
AMN Analyst Ratings
Bulls say
AMN Healthcare Services Inc reported a revenue of $658.2 million for the second quarter of 2025, which, despite being down 11% year-over-year, surpassed the estimates of both the analyst and consensus. The company's gross margin increased to 29.8%, exceeding the high-end of its guidance by 120 basis points, while the gross margin for the nurse and allied solutions segment rose to 28.2%. Moreover, AMN has consistently demonstrated strong performance with an average revenue surprise of +3% and an EBITDA surprise of +12% over the past four quarters, highlighting its ability to outperform expectations.
Bears say
AMN Healthcare Services Inc reported a decrease in segment revenue for its nurse and allied solutions segment, falling 9% year-over-year to $101.8 million, despite exceeding estimates. The company's physician and leadership solutions segment also faced challenges, with revenues declining 14% year-over-year to $381.9 million, although it slightly surpassed expectations. Additionally, the overall operating margin fell by 30 basis points quarter-over-quarter to 7.5%, indicating tightening profit margins amid a challenging revenue environment, particularly with a significant 31% year-over-year drop in vendor management system revenue.
This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.
AMN Analyst Forecast & Price Prediction
Start investing in AMN
Order type
Buy in
Order amount
Est. shares
0 shares